# Wieslab AB

- Location (FDA's records): Frederick, MD
- FDA decisions: 5 (1998–1998): 5 510(k) clearances
- Product codes: MOB (4), DBL (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 1 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Phadia US, Inc.: 1 (https://510kreport.com/company/phadia-us)

## Its most-cited devices
- K974169: Wielisa Anti-GBM Test System (1998), cited by 1

## Recent decisions
- K981750: Wielisa Anti-GBM, Anca Screening Kit Test System (Jul 22, 1998)
- K981748: Wielisa Anca Screening Kit Test System (Jul 22, 1998)
- K974167: Wielisa PR-3 Anca Test System (Feb 17, 1998)
- K974169: Wielisa Anti-GBM Test System (Feb 17, 1998)
- K974166: Wielisa Mpo Anca Test System (Feb 17, 1998)

Source page: https://510kreport.com/company/wieslab
